# Horizon Europe

> Horizon Europe is a VC fund in The Hague backing Health Care and Biotechnology. See 53 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: The Hague, The Netherlands
- Total investments: 53
- Last investment: Jul 2026
- Lead investor: 74%
- Last updated: Aug 2026
- Website: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/programmes/horizon

Horizon Europe is an European Union's research & innovation framework programme for 2021-2027.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 13 | 25% |
| Biotechnology | 12 | 23% |
| Medical | 9 | 17% |
| Manufacturing | 7 | 13% |
| Energy | 6 | 11% |

76 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 43 | 81% |
| Pre-Seed | 3 | 6% |
| Seed | 1 | 2% |
| Post-IPO Equity | 1 | 2% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 7 | 13% |
| United Kingdom | 7 | 13% |
| Sweden | 6 | 11% |
| Denmark | 4 | 8% |
| Spain | 3 | 6% |

20 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Viavi Solutions | Viavi (NASDAQ: VIAV) software and hardware platforms and instruments deliver end-to-end visibility across physical, virtual and hybrid networks. Precise intelligence and actionable insight from across the network ecosystem optimizes the service experience for increased customer loyalty, greater profitability and quicker transitions tonext-generation technologies. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications. | $1.1M | Grant | Jul 14, 2026 |  |
| Omnix Medical | Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technologywill tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide. | $9.1M | Grant | Jul 13, 2026 |  |
| Azalea Vision | Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders. | $2.9M | Grant | Jul 01, 2026 |  |
| Lucian Blaga University of Sibiu | Lucian Blaga University of Sibiu is a school in Sibiu. | $250.6K | Grant | Jun 30, 2026 |  |
| SK Telecom | SK Telecom is dedicated to developing advanced telecommunications technologies for the mobile lifestyle. SK Telecom has established an ecosystem by forming strategic alliances with Asia's information communications operators. In addition, they actively participate in a variety of international cooperation activities with overseastelecommunication institutions, as well as international organizations including the ITU, PTC and CDG, and more. Through such efforts, they continue to reinforce their competency and reach out to the world. |  | Grant | Jun 09, 2026 |  |
| Pasteur Institute | The Pasteur Institute is a biomedical research institute. | $17.6M | Grant | Jun 08, 2026 |  |
| NETRIS Pharma | NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the pharmaceutical industry. The dependence receptors are trans-membrane proteins that receive signals and transmit them inside cells and this helps in controlling tumor development. The company provides vitro and in vivo research, preclinicalpractices for manufacturing drugs for the treatment of breast cancer, lung cancer, glioblastoma and neuroblastoma cancer. | $8.4M | Grant | May 28, 2026 |  |
| Greenland Resources | Greenland Resources focuses on the development of its flagship project called Malmbjerg, a climax-type pure molybdenum mineral deposit near tidewater in east-central Greenland. | $568.6K | Grant | May 21, 2026 |  |
| Irish Manufacturing Research | Irish Manufacturing Research is a consulting firm that assists with training, membership, funding opportunities, and business linkages. | $8M | Grant | May 19, 2026 |  |
| Greenland Resources | Greenland Resources focuses on the development of its flagship project called Malmbjerg, a climax-type pure molybdenum mineral deposit near tidewater in east-central Greenland. | $58.6M | Post-IPO Equity | Apr 27, 2026 |  |

10 of 53 investments shown.

## Co-investors
- [Coalition for Epidemic Preparedness Innovations](https://shizune.co/investors/profile/coalition-for-epidemic-preparedness-innovations-cepi) — VC Fund, 2 deals together
- 6G Smart Networks and Services Industry Association — VC Fund, 1 deal together
- Airbus Développement — VC Fund, 1 deal together
- [AWS Activate](https://shizune.co/investors/profile/aws-activate-ec0d) — VC Fund, 1 deal together
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 1 deal together
- [European Commission](https://shizune.co/investors/profile/european-commission) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Horizon Europe invest in?

Horizon Europe invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Pre-Seed stage. Most of the 53 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Horizon Europe last invest?

The most recent investment recorded for Horizon Europe closed in Jul 2026. Shizune tracks 53 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co